Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
about
Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma.The ceramide pathway is involved in the survival, apoptosis and exosome functions of human multiple myeloma cells in vitro.Clinical pharmacokinetics of oral drugs in the treatment of multiple myeloma.The application of CAR-T cell therapy in hematological malignancies: advantages and challenges
P2860
Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Role of Immunotherapy in Targe ...... Evolving Therapeutic Strategy.
@en
type
label
Role of Immunotherapy in Targe ...... Evolving Therapeutic Strategy.
@en
prefLabel
Role of Immunotherapy in Targe ...... Evolving Therapeutic Strategy.
@en
P2860
P356
P1433
P1476
Role of Immunotherapy in Targe ...... Evolving Therapeutic Strategy.
@en
P2093
Clement Chung
P2860
P304
P356
10.1002/PHAR.1871
P407
P577
2016-11-21T00:00:00Z